Literature DB >> 15199154

Phosphorylation by protein kinase CK2 changes the DNA binding properties of the human chromatin protein DEK.

Ferdinand Kappes1, Catalina Damoc, Rolf Knippers, Michael Przybylski, Lorenzo A Pinna, Claudia Gruss.   

Abstract

We have examined the posttranslational modification of the human chromatin protein DEK and found that DEK is phosphorylated by the protein kinase CK2 in vitro and in vivo. Phosphorylation sites were mapped by quadrupole ion trap mass spectrometry and found to be clustered in the C-terminal region of the DEK protein. Phosphorylation fluctuates during the cell cycle with a moderate peak during G(1) phase. Filter binding assays, as well as Southwestern analysis, demonstrate that phosphorylation weakens the binding of DEK to DNA. In vivo, however, phosphorylated DEK remains on chromatin. We present evidence that phosphorylated DEK is tethered to chromatin throughout the cell cycle by the un- or underphosphorylated form of DEK.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15199154      PMCID: PMC480878          DOI: 10.1128/MCB.24.13.6011-6020.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

1.  The ubiquitous chromatin protein DEK alters the structure of DNA by introducing positive supercoils.

Authors:  Tanja Waldmann; Carmen Eckerich; Martina Baack; Claudia Gruss
Journal:  J Biol Chem       Date:  2002-05-07       Impact factor: 5.157

2.  Transcriptional activation by AP-2alpha is modulated by the oncogene DEK.

Authors:  Mónica Campillos; Miguel Angel García; Fernando Valdivieso; Jesús Vázquez
Journal:  Nucleic Acids Res       Date:  2003-03-01       Impact factor: 16.971

3.  Protein interactions targeting the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus to cell chromosomes.

Authors:  Anita Krithivas; Masahiro Fujimuro; Magdalena Weidner; David B Young; S Diane Hayward
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

4.  Autoantibodies to DEK oncoprotein in human inflammatory disease.

Authors:  X Dong; J Wang; F N Kabir; M Shaw; A M Reed; L Stein; L E Andrade; V F Trevisani; M L Miller; T Fujii; M Akizuki; L M Pachman; M Satoh; W H Reeves
Journal:  Arthritis Rheum       Date:  2000-01

5.  Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells.

Authors:  Maria Ruzzene; Daniele Penzo; Lorenzo A Pinna
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

6.  Apoptotic cleavage of scaffold attachment factor A (SAF-A) by caspase-3 occurs at a noncanonical cleavage site.

Authors:  M Kipp; B L Schwab; M Przybylski; P Nicotera; F O Fackelmayer
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

7.  Purification of the pets factor. A nuclear protein that binds to the inducible TG-rich element of the human immunodeficiency virus type 2 enhancer.

Authors:  G K Fu; D M Markovitz
Journal:  J Biol Chem       Date:  1996-08-09       Impact factor: 5.157

8.  Autoantibodies to DEK oncoprotein in systemic lupus erythematosus (SLE).

Authors:  I Wichmann; N Respaldiza; J R Garcia-Lozano; M Montes; J Sanchez-Roman; A Nuñez-Roldan
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

Review 9.  Toward the rational design of protein kinase casein kinase-2 inhibitors.

Authors:  Stefania Sarno; Stefano Moro; Flavio Meggio; Giuseppe Zagotto; Diego Dal Ben; Paola Ghisellini; Roberto Battistutta; Giuseppe Zanotti; Lorenzo A Pinna
Journal:  Pharmacol Ther       Date:  2002 Feb-Mar       Impact factor: 12.310

10.  Daxx and histone deacetylase II associate with chromatin through an interaction with core histones and the chromatin-associated protein Dek.

Authors:  Andrew D Hollenbach; Craig J McPherson; Edwin J Mientjes; Rekha Iyengar; Gerard Grosveld
Journal:  J Cell Sci       Date:  2002-08-15       Impact factor: 5.285

View more
  50 in total

1.  Functional domains of the ubiquitous chromatin protein DEK.

Authors:  Ferdinand Kappes; Ingo Scholten; Nicole Richter; Claudia Gruss; Tanja Waldmann
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

Review 2.  Control of tumorigenesis and chemoresistance by the DEK oncogene.

Authors:  Erica Riveiro-Falkenbach; María S Soengas
Journal:  Clin Cancer Res       Date:  2010-05-25       Impact factor: 12.531

3.  Development and exploitation of CK2 inhibitors.

Authors:  Stefania Sarno; Maria Ruzzene; Pietrogiulio Frascella; Mario A Pagano; Flavio Meggio; Alfonso Zambon; Marco Mazzorana; Giovanni Di Maira; Vittorio Lucchini; Lorenzo A Pinna
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

4.  The DEK nuclear autoantigen is a secreted chemotactic factor.

Authors:  Nirit Mor-Vaknin; Antonello Punturieri; Kajal Sitwala; Neil Faulkner; Maureen Legendre; Michael S Khodadoust; Ferdinand Kappes; Jeffrey H Ruth; Alisa Koch; David Glass; Lilli Petruzzelli; Barbara S Adams; David M Markovitz
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

5.  DEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigen.

Authors:  Nirit Mor-Vaknin; Ferdinand Kappes; Amalie E Dick; Maureen Legendre; Catalina Damoc; Seagal Teitz-Tennenbaum; Roland Kwok; Elisa Ferrando-May; Barbara S Adams; David M Markovitz
Journal:  Arthritis Rheum       Date:  2011-02

6.  The nuclear DEK interactome supports multi-functionality.

Authors:  Eric A Smith; Eric F Krumpelbeck; Anil G Jegga; Malte Prell; Marie M Matrka; Ferdinand Kappes; Kenneth D Greis; Abdullah M Ali; Amom R Meetei; Susanne I Wells
Journal:  Proteins       Date:  2017-11-11

7.  Chromatin redistribution of the DEK oncoprotein represses hTERT transcription in leukemias.

Authors:  Maroun Karam; Morgan Thenoz; Valérie Capraro; Jean-Philippe Robin; Christiane Pinatel; Agnès Lancon; Perrine Galia; David Sibon; Xavier Thomas; Sophie Ducastelle-Lepretre; Franck Nicolini; Mohamed El-Hamri; Youcef Chelghoun; Eric Wattel; Franck Mortreux
Journal:  Neoplasia       Date:  2014-01       Impact factor: 5.715

Review 8.  The DEK oncoprotein and its emerging roles in gene regulation.

Authors:  C Sandén; U Gullberg
Journal:  Leukemia       Date:  2015-03-13       Impact factor: 11.528

Review 9.  Fly Fishing for Histones: Catch and Release by Histone Chaperone Intrinsically Disordered Regions and Acidic Stretches.

Authors:  Christopher Warren; David Shechter
Journal:  J Mol Biol       Date:  2017-06-10       Impact factor: 5.469

Review 10.  Stacking the DEK: from chromatin topology to cancer stem cells.

Authors:  Lisa M Privette Vinnedge; Ferdinand Kappes; Nicolas Nassar; Susanne I Wells
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.